Understanding vulvodynia

Australasian Journal of Dermatology

Volumn 39, Issue 3, 1998, Pages 139-150

  Byth, Jenny L ^a  

^a WESLEY HOSPITAL   (Australia)

Author keywords

Burning vulva syndrome; Dysaesthetic vulvodynia; Pudendal neuralgia; Recurrent vulvovaginal candidiasis; Vulvar pain; Vulvar vestibulitis

Indexed keywords

CANDIDIASIS; COMORBIDITY; FEMALE; HUMAN; NEURALGIA; PATHOGENESIS; RECURRENT INFECTION; REVIEW; VULVA DISEASE;

EID: 0031857908     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1998.tb01270.x     Document Type: Review

References (67)

1. Burning vulva syndrome: Report of the ISSVD taskforce. J. Reprod. Med. 1984; 29: 457.
2. Sobel JD. Controversial aspects in the management of vulvovaginal candidiasis. J. Am. Acad. Dennatol. 1994; 31: S10-13.
3. Sobel JD. Vulvovaginitis. Dennatol. Clin. 1992; 10: 339-59.
4. Odds FC. Pathogenesis of Candida infections. J. Am. Acad. Dennatol. 1994; 31: S3-5.
5. Ashman RB, OU AK. Autoimmunity as a factor in recurrent vaginal candidiasis and the minor vestibular gland syndrome. J. Reprod. Med. 1989; 34: 264-6.
6. Marinoff SC, Turner M LC. Hypersensitivity to vaginal candidiasis or treatment vehicles in the pathogenesis of minor vestibular gland . syndrome. J. Reprod. Med. 1986; 31: 796-9.
7. McKay M. Vulvodynia: Diagnostic patterns. Dennatol. Clin. 1992; 10: 423-3.
8. Roth AC, Forssman L, Warden P. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin, Med. 1990; GO: 357-60.
9. Sobel JD. Recurrent vulvovaginal candidiasis: A prospective study of the efficacy of maintenance ketoconazole therapy. A'. Engl. J.Med. 1986; 315: 1455-8.
10. Dennerstein G. Recurrent Candidiasis Management Strategies. Proceedings of the 2nd Symposium on Diseases of the Vulva and Vagina, Melbourne, Oct 1994.
11. Rigg D, Miller MM, Metzger WJ. Recurrent allergic vulvovaginitis: Treatment with Candida albicans allergen immunotherapy. Am. J. Obstet. Gynecol. 1990; 162: 332-6.
12. Dennerstein GJ, Scurry JP, Garland SM et al. Human papillomavirus rulvitis: A new disease or an unfortunate mistake? Br. J. Obstet. Gynaecol. 1994; 101: 992-8.
13. Fischer GO. The commonest causes of symptomatic vulvar disease: A dermatologist's perspective. Auslralas. J. Dernialol. 1996; 37: 12-18.
14. Fischer G, Spurrett B, Fischer A. The chronically symptomatic vulva: Aetiology and management Br. J. Obstet. Gynaecol. 1995; 102: 773-9.
15. Friedrich EG Jr. Vulvar vestibulitis syndrome. J. Reprod. Med. 1987; 32: 110-14.
16. Marinoff SC, TUrner LC. Vulvar vestibulitis syndrome. Dermatol. Clin. 1992; 10: 435-44.
17. Mann MS, Kaufman RH, Brown D Jr, Adam E. Vulvar vestibulitis: Significant clinical variables and treatment outcome. Obstet. Gynecol. 1992; 79: 122-5.
18. Goetsch MF. Vulvar vestibulitis: Prevalence and historic features in a general gynecologic practice population. Am. J. Obslet. Gynecol. 1991; 161: 1609-16.
19. Chaim W, Meriwether C, Gonik B, Qureshi F, Sobel JD. Vulvar vestibulitis subjects undergoing surgical intervention: A descriptive analysis and histopathological correlates. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996; 68: 165-8.
20. McKay M. Vulvodynia: A multifactorial clinical problem. Arch. DcnnatoL 1989; 123: 256-62.
21. Bornstcin J, Shapiro S, Rabat M el at. Polymerase chain reaction search for viral etiology of vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol. 1996; 175: 139-44.
22. Goldsborough MD, McAlIister P, Reid R, Temple G, Lorincz AT. A comparison study of human papillomavirus prevalence by the polymerase chain reaction in low risk women and in a gynaecology referral group at elevated risk for cervical cancer. Mol. Cell. Probes 1992; 6: 451-7.
23. Marinoff SC, Turner MLC. Vulvar vestibulitis syndrome: An overview. Am. J. Obstet. Gynecol. 1991; 163: 1228-33.
24. Solomons CC, Melmed MH, Heifler SM. Calcium citrate for vulvar vestibulitis: A case report. J. Reprod. Med. 1991; 36: 879-82.
25. Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am, J. Obstet. Gynecol. 1997; 177: 507-11.
26. Schover LS, Youngs DD, Cannata R. Psychosexual aspects of the evaluation and management of vulvar vestibulitis. Am. J. Obstet. Gynecol. 1991; 167:630-6.
27. Jantos M, mute G. The vestibulitis syndrome: Medical and psychosexual assessment of a cohort of patients. J. Reprod. Med. 1997; 42: 145-52.
28. Van Lankveld JJ, Weifenborg PT, 1er Kuile MM. Psychologic profiles of and sexual function in women with vulvar vestibulitis and their partners. Obstet. Gynecol. 1996; 88: 65-70.
29. Meana M, Binik YM, Khalife S, Cohen DR. Biopsychosocial profile of women with dyspareunia. Obstet. Gynecol. 1997; 90: 583-9.
30. Edwards L, Mason M, Phillips M, Norton J, Boyle M. Childhood sexual and physical abuse: Incidence in patients with vulvodynia. J. Reprod. Med. 1997; 42: 135-9.
31. Bazin S, Bouchard C, Brisson J, Morin C, Meiseis A, Fortier M. Vulvar vestibulitis syndrome: An exploratory case-control study. Obslet. Gynecol. 1994; 83: 47-50.
32. Costello C. Vulvodynia associated with coeliac disease. Dr. J. Obstet. Gynaecol. 1996; 103: 1162-3.
33. McCormack WM. Two urogenital sinus syndromes: Interstitial cystitis and focal vulvitis. J. Reprod. Med. 1990; 35: 873-6.
34. Fitzpatrick CG, DeLancey JOL, Elkins TE, McGuire EJ. Vulvar vestibulitis and interstitial cystitis: A disorder of urogenital sinusderived epithelium? Obstet. Gynecol. 1993; 81: 8GO-2.
35. Foster DC, Hasday JD. Elevated tissue levels of interleukin-lß and tumor necrosis factor a in vulvar vestibulitis. Obstet. Gynecol. 1997; 89:291-6.
36. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence. Pain 1993; 52:259-85.
37. Wall PD. Noradrenaline-evoked pain in neuralgia. Pain 1995; 63: 1-2.
38. Dotson RM. Causalgia-reflex sympathetic dystrophy-sympathetically maintained pain: Myth and reality. Muscle Nerve 1993; 16: 1049-55.
39. Warner TF, Tomic S, Chang CK. Neuroendocrine cell-axonal complexes in the minor vcstibular gland. J. Reprod. Med. 1996; 41: 397-402.
40. Cox JT. Deconstructing vulvar pain. Lancet 1995; 545: 53.
41. Foster DC, Robinson JC, Davis KM. Urethral pressure variation in women with vulvar vestibulitis syndrome. Am. J. Obslet. Gynecol. 1993; 169: 107-12.
42. White G, Jantos M, Glazer H. Establishing the diagnosis of vulvar vestibulitis. J. Reprod. Med. 1997; 42: 157-60.
43. Reid R, Omoto KH, Precop SL et al. Flashlamp-cxcited dye laser therapy of idiopathic vulrodynia is safe and efficacious. Am. J. Obstet. Gynecol. 1995; 172: 1684-701.
44. Friedrich EG. Therapeutic studies on vulvar vestibulitis. J. Reprod, Med. 1988; 33: 514-17.
45. Rumsfield JA, West DP. Topical capsaicin in dermatologie and peripheral pain disorders. DICP An. Pharmacolher. 1991; 25: 381-7.
46. Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J. Reprod. Med. 1995; 40:283-90.
47. Horowitz BJ. Interferon therapy for condylomatous vulvitis. Obstet. Gynecol. 1989; 73: 446-8.
48. Marinoff SC, Turner ML, Hirsch RP, Richard G. Intralesional (interferon: Cost-effective therapy for vulvar vestibulitis syndrome. J. Reprod. Med. 1993; 38: 19-24.
49. Bornstein J, Pascal B, Abramovici II. Intramuscular ßInterferon treatment for severe vulvar vestibulitis. J. Reprod. Med. 1993; 38: 117-20.
50. Woodruff JD, Parmley Til. Infection of the minor vestibular gland. Obstet. Gynecol. 1983; 62: 609-12.
51. Bergeron S, Binik Y, Khalife S, Pagidas K. Vulvar vestibulitis syndrome: A critical review. Clin. J. Pain 1997; 13: 27-42.
52. Bornstein J, Abramovici 11. Combination of subtotal perineoplasty and interferon for the treatment of vulvar vestibulitis. Gynecol. Obstet. Invest. 1997; 44: 53-6.
53. Goetsch MF. Simplified surgical revision of the vulvar vestibule for vulvar vestibulitis. Arn. J. Obstet. Gynecol. 1996; 174: 1701-7.
54. Bornstein J, Zarfati D, Goldik Z, Abramovici H. Perineoplasty compared with vestibuloplasty for severe vulvar vestibulitis. Dr. J. Obstet. Gynaccol. 1995; 102: 652-5.
55. Schnitz WCMW, Gianotten WL, van der Meijden WI et al. Behavioral approach with or without surgical intervention to the vulvar vestibulitis syndrome: A prospective randomized and nonrandomized study.J. Psychosom. Obstet. Gynecol. 1996; 17:143-8.
56. Bornstein J, Goldik Z, Stolar Z, Zarfati D, Abramovici II. Predicting the outcome of surgical treatment of vulvar vestibulitis. Obstet. G)-necol. 1997; 89: 695-8.
57. Bornstein J, Shapiro S, Goldshmid N, Goldik Z, Lahat N, Abramovici II. Severe vulvar vestibulitis: Relation to IIPV infection. J. Reprod. Med. 1997; 42: 514-18.
58. Abramov L, Wolman I, David MP. Vaginismus: An important factor in the evaluation and management of vulvar vestibulitis syndrome. Gynecol. Obstct. Invest. 1994; 38: 194-7.
59. McKay M. Dysaesthetic ('essential') vulvodynia: Treatment with amitriptyline. J. Keprod. Mcd. 1993; 38: 9-13.
60. Turner MLC, Marinoff SC. Pudendal neuralgia. Am. J. Obstet. GjTiecol. 1994; 165: 1233-G.
61. BensonJT.Neurophysiology of the female pelvic floor. Curr. Opin. Obstet. G)-nccol. 1994; 6: 320-3.
62. Sonni L, Cattaneo A, De Marco A, De Magnis A, Carli P, Marabini S. Idiopathic vulvodynia: Clinical evaluation of the pain threshold with acetic acid solutions. J. Reprod. Med. 1993; 40: 337-41.
63. Van de Rieft E, Van Vyve M. Chronic perineal pain related to sacral meningeal cysts. Neurosurgety 1991; 29: 223-6.
64. Lewis FM, Harrington CI. Use of magnetic resonance imaging in vulvodynia. J. Reprod. Med. 1997; 42: 169.
65. Lambiris A, Greaves MW. Urticaria: Increasingly recognized but not adequately highlighted cause of dyspareunia and vulvodynia. Ada Derm. Venereal 1997; 77: 160-1.
66. Perniciaro C, Bustamante AS Jr, Gutierrez M. Two cases of vulvodynia with unusual causes. Ada Denn. Venereal. 1993; 73:227-8.
67. Wesselmann U, Reich S. The dynias. Semin. Neural. 1996; 16: 63-74.